Guardant Health (GH) Tops Q3 EPS by 21c
Get Alerts GH Hot Sheet
Join SI Premium – FREE
Guardant Health (NASDAQ: GH) reported Q3 EPS of ($1.18), $0.21 better than the analyst estimate of ($1.39). Revenue for the quarter came in at $117.4 million versus the consensus estimate of $118.08 million.
For earnings history and earnings-related data on Guardant Health (GH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guardant Health (GH) PT Raised to $210 at BTIG, remains Top Pick
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share